(S)-2-((R)-1-(Diphenylphosphanyl)piperidin-2-yl)-4-isopropyl-4,5-dihydrooxazole

Catalog No. :
ACWGIZ642
CAS No. :
2757084-56-1
Molecular Formula :
C23H29N2OP
Molecular Weight :
380.47

IUPAC Name:(S)-2-((R)-1-(diphenylphosphaneyl)piperidin-2-yl)-4-isopropyl-4,5-dihydrooxazole

(S)-2-((R)-1-(Diphenylphosphanyl)piperidin-2-yl)-4-isopropyl-4,5-dihydrooxazole structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$68.00Login to see priceIn stockInquiry
100mg97%$107.00Login to see priceIn stockInquiry
250mg97%$182.00Login to see priceIn stockInquiry
1g97%$725.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(S)-2-((R)-1-(Diphenylphosphanyl)piperidin-2-yl)-4-isopropyl-4,5-dihydrooxazole
IUPAC Name(S)-2-((R)-1-(diphenylphosphaneyl)piperidin-2-yl)-4-isopropyl-4,5-dihydrooxazole
Molecular FormulaC23H29N2OP
Molecular Weight380.47
SMILESCC([C@@H]1N=C([C@@H]2N(P(C3=CC=CC=C3)C4=CC=CC=C4)CCCC2)OC1)C
InChI KeyPQUUCDVLTJZOFT-FGZHOGPDSA-N
SynonymPiperidine, 2-[(4S)-4,5-dihydro-4-(1-methylethyl)-2-oxazolyl]-1-(diphenylphosphino)-, (2R)-
CAS No.2757084-56-1
PubChem CID162394364

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H319-H413
Precautionary Statement(s)
P264-P273-P280-P305+P351+P338-P337+P313-P501

Synthetic Route by SureRoute

1. ACWGIZ642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACWGIZ642 route product structure diagram
    ACWGIZ6422757084-56-1 In Stock
Inquiry

2. ACWGIZ642 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACWGIZ642 route product structure diagram
    ACWGIZ6422757084-56-1 In Stock
Inquiry

Comments (0)